| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9382 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8723 |
| P-glycoprotein Substrate | Non-substrate | 0.8000 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9640 |
| Non-inhibitor | 0.9809 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8650 |
| Distribution |
| Subcellular localization | Lysosome | 0.7280 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8029 |
| CYP450 2D6 Substrate | Non-substrate | 0.9115 |
| CYP450 3A4 Substrate | Non-substrate | 0.7860 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7534 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9731 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8424 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8337 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9273 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8611 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9486 |
| Non-inhibitor | 0.9655 |
| AMES Toxicity | Non AMES toxic | 0.9105 |
| Carcinogens | Non-carcinogens | 0.7070 |
| Fish Toxicity | Low FHMT | 0.7685 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8001 |
| Honey Bee Toxicity | Low HBT | 0.5384 |
| Biodegradation | Ready biodegradable | 0.5786 |
| Acute Oral Toxicity | III | 0.8774 |
| Carcinogenicity (Three-class) | Non-required | 0.7060 |